Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Bock

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Opinion in Chemical Biology|August 26, 2000
Bradykinin antagonists: new opportunitiesM G Bock, J Longmore
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and biological activity of 3-amino-5-(3,5-diamino-6-chloropyrazin-2-yl)-1,2,4-oxadiazole: an amiloride prodrugM G Bock, R L Smith, E H Blaine, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2001
Determination of the relative and absolute stereochemistry of a potent and alpha1A-selective adrenoceptor antagonistB Lagu, J M Wetzel, C Forray, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Progress in the development of oxytocin antagonists for use in preterm laborP D Williams, M G Bock, B E Evans, et al.
Molecular Pharmacology|June 1, 1989
Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligandR S Chang, T B Chen, M G Bock, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonistsJ B Nerenberg, J M Erb, J M Bergman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivityM A Patane, R M DiPardo, R P Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Life Sciences|January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.
Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Opinion in Chemical Biology|August 26, 2000
Bradykinin antagonists: new opportunitiesM G Bock, J Longmore
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and biological activity of 3-amino-5-(3,5-diamino-6-chloropyrazin-2-yl)-1,2,4-oxadiazole: an amiloride prodrugM G Bock, R L Smith, E H Blaine, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2001
Determination of the relative and absolute stereochemistry of a potent and alpha1A-selective adrenoceptor antagonistB Lagu, J M Wetzel, C Forray, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Progress in the development of oxytocin antagonists for use in preterm laborP D Williams, M G Bock, B E Evans, et al.
Molecular Pharmacology|June 1, 1989
Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligandR S Chang, T B Chen, M G Bock, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonistsJ B Nerenberg, J M Erb, J M Bergman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivityM A Patane, R M DiPardo, R P Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Life Sciences|January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesD J Pettibone, M T Kishel, C J Woyden, et al.
Journal of Medicinal Chemistry|January 1, 1988
Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepinesM G Bock, R M DiPardo, B E Evans, et al.
Pageof 4